Background and General

Our discussions below in this Item 7 should be read in conjunction with our consolidated financial statements, including the notes thereto, included in this annual report on Form 10-K.



We are a producer and distributor of premium specialty alloys, including
titanium alloys, powder metals, stainless steels, alloy steels, and tool steels.
We are a recognized leader in high-performance specialty alloy-based materials
and process solutions for critical applications in the aerospace, defense,
medical, transportation, energy, industrial and consumer markets. We have
evolved to become a pioneer in premium specialty alloys, including titanium,
nickel, and cobalt, as well as alloys specifically engineered for additive
manufacturing ("AM") processes and soft magnetics applications. We have expanded
our AM capabilities to provide a complete "end-to-end" solution to accelerate
materials innovation and streamline parts production. We primarily process basic
raw materials such as nickel, cobalt, titanium, manganese, chromium, molybdenum,
iron scrap and other metal alloying elements through various melting, hot
forming and cold working facilities to produce finished products in the form of
billet, bar, rod, wire and narrow strip in many sizes and finishes. We also
produce certain metal powders and parts. Our sales are distributed directly from
our production plants and distribution network as well as through independent
distributors. Unlike many other specialty steel producers, we operate our own
worldwide network of service and distribution centers. These service centers,
located in the United States, Canada, Mexico, Europe and Asia allow us to work
more closely with customers and to offer various just-in-time stocking programs.

As part of our overall business strategy, we have sought out and considered
opportunities related to strategic acquisitions and joint collaborations as well
as possible business unit dispositions aimed at broadening our offering to the
marketplace. We have participated with other companies to explore potential
terms and structures of such opportunities and expect that we will continue to
evaluate these opportunities.

While we prepare our financial statements in accordance with U.S. generally
accepted accounting principles ("U.S. GAAP"), we also utilize and present
certain financial measures that are not based on or included in U.S. GAAP (we
refer to these as "Non-GAAP financial measures"). Please see the section
"Non-GAAP Financial Measures" below for further discussion of these financial
measures, including the reasons why we use such financial measures and
reconciliations of such financial measures to the nearest U.S. GAAP financial
measures.

                                       20
--------------------------------------------------------------------------------
  Table of Contents
Business Trends

Selected financial results for the past three fiscal years are summarized below:


                                                                    Years Ended June 30,
($ in millions, except per share data)                       2021           2020           2019
Net sales                                                 $ 1,475.6      $ 

2,181.1 $ 2,380.2



Net sales excluding surcharge revenue (1)                 $ 1,252.8      $ 1,828.7      $ 1,942.1

Operating (loss) income                                   $  (248.6)     $    25.3      $   241.4

Net (loss) income                                         $  (229.6)     $     1.5      $   167.0

Diluted (loss) earnings per share                         $   (4.76)     $  

0.02 $ 3.43

Purchases of property, plant, equipment and software $ 100.5 $


 171.4      $   180.3

Free cash flow (1)                                        $   132.0      $    21.8      $   (53.7)

Pounds sold (in thousands) (2)                              169,706        

231,736 267,536

(1) See the section "Non-GAAP Financial Measures" below for further discussion of these financial measures.

(2) Includes pounds from Specialty Alloys Operations segment, and certain Performance Engineered Products segment businesses including Dynamet and Additive businesses only.

Our sales are across diverse end-use markets. The table below summarizes our sales by end-use market over the past three fiscal years:



                                                        Years Ended June 30,
                                      2021                      2020                      2019
                                             % of                      % of                      % of
($ in millions)                Dollars       Total       Dollars       Total       Dollars       Total

Aerospace and Defense        $   710.9        48  %    $ 1,313.7        60  %    $ 1,327.9        56  %
Medical                          143.5        10  %        197.0         9  %        205.0         8  %
Transportation                   144.5        10  %        132.1         6  %        157.7         6  %
Energy                            87.8         6  %        135.4         6  %        181.7         8  %
Industrial and Consumer          292.1        20  %        296.0        14  %        371.5        16  %
Distribution                      96.8         6  %        106.9         5  %        136.4         6  %
Total net sales              $ 1,475.6       100  %    $ 2,181.1       100  %    $ 2,380.2       100  %



                                       21

--------------------------------------------------------------------------------
  Table of Contents
Impact of Raw Material Prices and Product Mix

We value most of our inventory utilizing the LIFO inventory costing methodology.
Under the LIFO inventory costing method, changes in the cost of raw materials
and production activities are recognized in cost of sales in the current period
even though these materials may have been acquired at potentially significantly
different values due to the length of time from the acquisition of the raw
materials to the sale of the processed finished goods to the customers. In a
period of rising raw material costs, the LIFO inventory valuation normally
results in higher cost of sales. Conversely, in a period of decreasing raw
material costs, the LIFO inventory valuation normally results in lower cost of
sales.
The volatility of the costs of raw materials has impacted our operations over
the past several years. We, and others in our industry, generally have been able
to pass cost increases on major raw materials through to our customers using
surcharges that are structured to recover increases in raw material
costs. Generally, the formula used to calculate a surcharge is based on
published prices of the respective raw materials for the previous month which
correlates to the prices we pay for our raw material purchases. However, a
portion of our surcharges to customers may be calculated using a different
surcharge formula or may be based on the raw material prices at the time of
order, which creates a lag between surcharge revenue and corresponding raw
material costs recognized in cost of sales. The surcharge mechanism protects our
net income on such sales except for the lag effect discussed above. However,
surcharges have had a dilutive effect on our gross margin and operating margin
percentages as described later in this report.

Approximately 20 percent of our net sales are sales to customers under firm
price sales arrangements. Firm price sales arrangements involve a risk of profit
margin fluctuations, particularly when raw material prices are volatile. In
order to reduce the risk of fluctuating profit margins on these sales, we enter
into commodity forward contracts to purchase certain critical raw materials
necessary to produce the related products sold. Firm price sales arrangements
generally include certain annual purchasing commitments and consumption
schedules agreed to by the customers at selling prices based on raw material
prices at the time the arrangements are established. If a customer fails to meet
the volume commitments (or the consumption schedule deviates from the
agreed-upon terms of the firm price sales arrangements), the Company may need to
absorb the gains or losses associated with the commodity forward contracts on a
temporary basis. Gains or losses associated with commodity forward contracts are
reclassified to earnings/loss when earnings are impacted by the hedged
transaction. Because we value most of our inventory under the LIFO costing
methodology, changes in the cost of raw materials and production activities are
recognized in cost of sales in the current period attempting to match the most
recently incurred costs with revenues. Gains and/or losses on the commodity
forward contracts are reclassified from other comprehensive income (loss)
together with the actual purchase price of the underlying commodities when the
underlying commodities are purchased and recorded in inventory. To the extent
that the total purchase price of the commodities, inclusive of the gains or
losses on the commodity forward contracts, are higher or lower relative to the
beginning of year costs, our cost of goods sold reflects such amounts.
Accordingly, the gains and/or losses associated with commodity forward contracts
may not impact the same period that the firm price sales arrangements revenue is
recognized, and comparisons of gross profit from period to period may be
impacted. These firm price sales arrangements are expected to continue as we
look to strengthen our long-term customer relationships by expanding, renewing
and, in certain cases, extending to a longer term, our customer long-term
arrangements.

We produce hundreds of grades of materials, with a wide range of pricing and
profit levels depending on the grade. In addition, our product mix within a
period is subject to the fluctuating order patterns of our customers as well as
decisions we may make on participation in certain products based on available
capacity including the impacts of capacity commitments we may have under
existing customer agreements. While we expect to see positive contribution from
a more favorable product mix in our margin performance over time, the impact by
period may fluctuate, and period to period comparisons may vary.
                                       22
--------------------------------------------------------------------------------
  Table of Contents
Net Pension Expense

Net pension expense, as we define it below, includes the net periodic benefit costs related to both our pension and other postretirement plans. The net periodic benefit costs are determined annually based on beginning of year balances and are recorded ratably throughout the fiscal year, unless a significant re-measurement event occurs.



During the fiscal year ended June 30, 2021, we evaluated the need for settlement
accounting under Accounting Standards Codification ("ASC') 715-30-35-82 based on
the higher than normal lump-sum payments made during the current fiscal year in
our largest defined benefit plan. We determined that the lump-sum payments
exceeded the threshold of service cost and interest cost components and
settlement accounting was required. We recorded a settlement charge of $11.4
million in the year ended June 30, 2021 within other expense (income), net.

The following is a summary of the net periodic benefit costs for the years ended June 30, 2021, 2020 and 2019:


                                       Years Ended June 30,
($ in millions)                    2021         2020        2019
Pension plans                   $   21.3      $ 12.2      $  9.8
Other postretirement plans           3.3         3.1         1.8
Net periodic benefit costs      $   24.6      $ 15.3      $ 11.6



The service cost component of net pension expense represents the estimated cost
of future pension liabilities earned associated with active employees. The
pension earnings, interest and deferrals is comprised of the expected return on
plan assets, interest costs on the projected benefit obligations of the plans
and amortization of actuarial gains and losses and prior service costs and
benefits.

During the year ended June 30, 2020, in connection with a restructuring plan, we
reduced our global salaried positions by twenty percent. In certain cases,
employees were eligible for severance benefits under one of our pension plans.
As a result, $3.5 million was funded from our qualified pension plan to cover
severance payments and medical coverage for impacted participants.

Net periodic benefit costs are recorded in accounts that are included in both
the cost of sales and selling, general and administrative expenses based on the
function of the associated employees and in other expense (income), net. The
following is a summary of the classification of net pension expense for the
years ended June 30, 2021, 2020 and 2019:

                                                                                Years Ended June 30,
($ in millions)                                                     2021                2020                2019

Service cost included in Cost of sales                         $      10.8

$ 11.0 $ 10.0



Service cost included in Selling, general and
administrative expenses                                                1.5                 1.5                 1.5

Pension earnings, interest and deferrals included in Other expense (income), net

                                            0.9                 2.8                 0.1

Settlement charge included in Other expense (income), net

                                                                   11.4                   -                   -
Net periodic benefit costs                                     $      24.6

$ 15.3 $ 11.6

As of June 30, 2021 and 2020, amounts capitalized in gross inventory were $1.0 million and $1.6 million, respectively.


                                       23
--------------------------------------------------------------------------------
  Table of Contents
Operating Performance Overview

For fiscal year 2021, we reported net loss of $229.6 million, or $4.76 loss per
diluted share, compared with net income of $1.5 million, or $0.02 earnings per
diluted share for fiscal year 2020. Our fiscal year 2021 ended strong with
overall end-use market conditions showing signs of recovery. We finished the
fiscal year with $582.0 million in total liquidity, including $287.4 million of
cash on hand. Fiscal year 2021 has been a challenging yet successful year for
Carpenter Technology. Over the past year we executed various portfolio
initiatives and targeted cost reductions, further implemented the Carpenter
Operating Model to secure notable productivity gains and generated $132 million
of free cash flow, which we define under "Non-GAAP Financial Measurers" below.
We also expanded and further strengthened key customer relationships and added
additional qualifications for our Athens, Alabama facility. We believe that our
efforts will prove critical to our financial position as demand conditions
across our end-use markets are strengthening, and we believe the beginning of a
broad-based recovery is taking shape. We remain a critical solutions provider
for our customers and have successfully deepened our relationships during the
downturn. The long-term outlook for our end-use markets remains attractive and
we are well positioned given our mission-critical solutions coupled with leading
capabilities and established supply chain position.

Results of Operations - Fiscal Year 2021 Compared to Fiscal Year 2020



For fiscal year 2021, we reported net loss of $229.6 million, or $4.76 loss per
diluted share. Excluding special items, loss per diluted share would have been
$2.01 for fiscal year 2021. This compares with net income of $1.5 million, or
$0.02 per diluted share, a year earlier. Excluding special items, earnings per
share would have been $2.36 per diluted share for fiscal year 2020. The results
for fiscal year 2021 compared to the same period a year ago were negatively
impacted by the significantly lower volume due to the COVID-19 pandemic,
targeted inventory reductions to strengthen liquidity and non-cash restructuring
and asset impairment charges. These headwinds were partially offset by the
various cost savings actions taken by us in fiscal year 2021 and the fourth
quarter of fiscal year 2020. Our fiscal year 2021 results were impacted by a
goodwill impairment charge totaling $52.8 million, LIFO decrement charges of
$52.2 million, COVID-19 charges of $17.3 million, restructuring and asset
impairment charges of $16.6 million, pension settlement charges of $11.4
million, debt extinguishment losses, net of $8.2 million and inventory
write-downs from restructuring of $4.2 million. The LIFO decrement charges are
non-cash charges associated with reducing inventory and liquidating LIFO layers
that have historical costs in excess of the current year inventory costs. Our
fiscal year 2020 results reflect goodwill impairment charges totaling $34.6
million, inventory write-downs and restructuring and asset impairment charges of
$97.8 million, LIFO decrement charges of $1.8 million and COVID-19 charges of
$7.4 million.

Net Sales

Net sales for fiscal year 2021 were $1,475.6 million, which was a 32 percent
decrease from fiscal year 2020. Excluding surcharge revenue, sales were 31
percent lower than fiscal year 2020 on 27 percent lower volume. The results
reflect the on-going financial disruptions caused by COVID-19, resulting in
lower sales across all end-use markets except transportation versus the prior
year period.

Geographically, sales outside the United States decreased 30 percent from fiscal
year 2020 to $549.0 million. The decrease was primarily due to lower product
demand in the Aerospace and Defense and Medical end-use markets in all regions.
A portion of our sales outside the United States are denominated in foreign
currencies. The impact of fluctuations in foreign currency exchange rates
resulted in a $3.8 million increase in sales during fiscal year 2021 compared to
fiscal year 2020. International sales as a percentage of our total net sales
represented 37 percent and 36 percent for fiscal year 2021 and fiscal year 2020,
respectively.

                                       24
--------------------------------------------------------------------------------
  Table of Contents
Sales by End-Use Markets

We sell to customers across diversified end-use markets. The following table
includes comparative information for our net sales, which includes surcharge
revenue, by principal end-use markets. We believe this is helpful supplemental
information in analyzing the performance of the business from period to period.


                                                                  Fiscal Year                        $
                                                                                                (Decrease)                   %
($ in millions)                                             2021               2020              Increase           (Decrease) Increase

Aerospace and Defense                                   $   710.9          $ 1,313.7          $     (602.8)                       (46) %
Medical                                                     143.5              197.0                 (53.5)                       (27) %
Transportation                                              144.5              132.1                  12.4                          9  %
Energy                                                       87.8              135.4                 (47.6)                       (35) %

Industrial and Consumer                                     292.1              296.0                  (3.9)                        (1) %
Distribution                                                 96.8              106.9                 (10.1)                        (9) %
Total net sales                                         $ 1,475.6          $ 2,181.1          $     (705.5)                       (32) %

The following table includes comparative information for our net sales by the same principal end-use markets, but excluding surcharge revenue:




                                                                  Fiscal Year                        $
                                                                                                (Decrease)                   %
($ in millions)                                             2021               2020              Increase           (Decrease) Increase

Aerospace and Defense                                   $   598.8          $ 1,072.1          $     (473.3)                       (44) %
Medical                                                     128.2              177.2                 (49.0)                       (28) %
Transportation                                              115.9              108.7                   7.2                          7  %
Energy                                                       70.5              116.4                 (45.9)                       (39) %

Industrial and Consumer                                     243.1              248.1                  (5.0)                        (2) %
Distribution                                                 96.3              106.2                  (9.9)                        (9) %
Total net sales excluding surcharge revenue             $ 1,252.8          $ 1,828.7          $     (575.9)                       (31) %



Sales to the Aerospace and Defense market decreased 46 percent from fiscal year
2020 to $710.9 million. Excluding surcharge revenue, sales decreased 44 percent
on 47 percent lower shipment volume. The results reflect weaker year-over-year
demand in all sub-markets due to the continued impact of lower aircraft OEM
build rates due to COVID-19 travel restrictions.

Sales to the Medical market decreased 27 percent to $143.5 million from fiscal
year 2020. Excluding surcharge revenue, sales decreased 28 percent on 24 percent
lower shipment volume. The results reflect lower demand as a result of the
medical supply chain managing inventory levels closely related to ongoing
concerns and delays of elective medical procedures due to the COVID-19 pandemic.

Transportation market sales of $144.5 million reflected a 9 percent increase
from fiscal year 2020. Excluding surcharge revenue, sales increased 7 percent on
12 percent higher shipment volume. The results reflect improved demand for
materials used in light-duty and heavy-duty vehicles in fiscal year 2021.

Sales to the Energy market of $87.8 million reflected a 35 percent decrease from
fiscal year 2020. Excluding surcharge revenue, sales decreased 39 percent. The
results reflect depressed North American drilling activity and decreased demand
globally as a result of the impact of COVID-19. This is slightly offset by
higher demand in power generation materials. The prior year results include a
full year of sales for the Amega West business, which we divested on September
30, 2020.

Industrial and Consumer market sales decreased 1 percent to $292.1 million for
fiscal year 2021. Excluding surcharge revenue, sales decreased 2 percent on 4
percent higher shipment volume. The flat results reflect the ongoing demand for
materials used in select industrial applications and steady demand for consumer
electronics and sporting goods.

                                       25
--------------------------------------------------------------------------------
  Table of Contents
Gross Profit

Gross profit in fiscal year 2021 decreased to $1.0 million, or 0.1 percent of
net sales, from $329.4 million, or 15.1 percent of net sales for fiscal year
2020. The current year results were impacted by significantly lower volume
resulting from the COVID-19 pandemic, continued targeted inventory reductions
which resulted in a $52.2 million LIFO decrement charge and $4.2 million of
inventory write-downs from restructuring. Excluding the impact of the surcharge
revenue, LIFO decrement and the inventory write-downs, our adjusted gross margin
in fiscal year 2021 was 4.6 percent compared to adjusted gross margin of 19.7
percent in fiscal year 2020.

Our surcharge mechanism is structured to recover increases in raw material
costs, although in certain cases with a lag effect as discussed above. While the
surcharge generally protects the absolute gross profit dollars, it does have a
dilutive effect on gross margin as a percent of sales. The following represents
a summary of the dilutive impact of the surcharge on gross margin excluding the
impact of the LIFO decrement and inventory write-downs from restructuring. We
present and discuss these financial measures because management believes
removing the impact of these items provides a more consistent and meaningful
basis for comparing results of operations from period to period. See the section
"Non-GAAP Financial Measures" below for further discussion of these financial
measures.
                                                                        Fiscal Year
($ in millions)                                                     2021            2020
Net sales                                                       $ 1,475.6       $ 2,181.1
Less: surcharge revenue                                             222.8           352.4
Net sales excluding surcharge revenue                           $ 1,252.8       $ 1,828.7

Gross profit                                                    $     1.0       $   329.4
LIFO decrement                                                       52.2             1.8
Inventory write-downs from restructuring                              4.2   

29.3


Gross profit excluding special items                            $    57.4       $   360.5

Gross margin                                                          0.1  %         15.1  %

Gross margin excluding surcharge revenue and special items            4.6  

% 19.7 %

Selling, General and Administrative Expenses



Selling, general and administrative expenses in fiscal year 2021 were $180.2
million, or 12.2 percent of net sales (14.4 percent of net sales excluding
surcharge revenue), compared to $201.0 million, or 9.2 percent of net sales
(11.0 percent of net sales excluding surcharge revenue), in fiscal year 2020.
The lower selling, general and administrative expenses in fiscal year 2021
reflect the impacts of the cost saving actions initiated in the fourth quarter
of fiscal year 2020 including lower salaries and benefits compared to the same
period a year ago.

Restructuring and Asset Impairment Charges



During fiscal year 2021, restructuring and asset impairment charges were $16.6
million compared to $68.5 million in fiscal year 2020. Additional restructuring
activities were executed in our Additive business in the PEP segment during
fiscal year 2021. This included $14.2 million of non-cash pre-tax impairment
charges consisting of $8.2 million of property, plant and equipment,
$4.3 million associated with certain definite lived intangible assets,
$1.3 million related to a lease right of use asset and $0.4 million of other
non-cash charges. We also recognized $0.4 million for facility shut-down costs
and various personnel costs for severance payments, medical coverage and related
items.

We recorded $2.0 million of non-cash impairment pre-tax charges as a result of
the Amega West business exit primarily related to accounts receivable determined
to be uncollectible.

Activities undertaken in connection with the fiscal year 2021 Additive restructuring plan are expected to be substantially complete in the first quarter of fiscal year 2022.


                                       26
--------------------------------------------------------------------------------
  Table of Contents
Goodwill Impairment Charge

Our long-term projections for the Additive reporting unit within the PEP segment
have been impacted by slower than expected growth in additive manufacturing
applications which was further compounded by the effects from COVID-19. As a
result, during fiscal year 2021 we recorded an impairment charge of $52.8
million, which represented the entire remaining balance of goodwill for this
reporting unit. During the fiscal year ended June 30, 2020 we recorded an
impairment charge of $34.6 million for the Additive reporting unit, which
represented a portion of the balance of the goodwill recorded for this reporting
unit.

Operating (Loss) Income

Our operating loss in fiscal year 2021 was $248.6 million, or 16.8 percent of
net sales, as compared with $25.3 million of operating income, or 1.2 percent of
net sales, in fiscal year 2020. Excluding surcharge revenue and special items,
adjusted operating margin was 8.4 percent for fiscal year 2021 and 9.1 percent
for fiscal year 2020. The results for fiscal year 2021 compared to the same
period a year ago were negatively impacted by the significantly lower volume due
to the COVID-19 pandemic, targeted inventory reductions to strengthen liquidity
and non-cash restructuring and asset impairment charges. These headwinds were
partially offset by the various cost savings actions taken in fiscal year 2021
and the fourth quarter of fiscal year 2020. Our fiscal year 2021 results were
also impacted by goodwill impairment charges totaling $52.8 million, LIFO
decrement charges of $52.2 million, COVID-19 charges of $17.3 million,
restructuring and asset impairment charges of $16.6 million, and inventory
write-downs from restructuring of $4.2 million.

The following presents our operating (loss) income and operating margin, in each
case excluding the impact of surcharge on net sales and excluding special items.
We present and discuss these financial measures because management believes
removing the impact of these items provides a more consistent and meaningful
basis for comparing results of operations from period to period. See the section
"Non-GAAP Financial Measures" below for further discussion of these financial
measures.
                                                                                       Fiscal Year
($ in millions)                                                                  2021               2020
Net sales                                                                    $ 1,475.6          $ 2,181.1
Less: surcharge revenue                                                          222.8              352.4
Net sales excluding surcharge revenue                                       

$ 1,252.8 $ 1,828.7



Operating (loss) income                                                      $  (248.6)         $    25.3

Special items:
LIFO decrement                                                                    52.2                1.8
COVID-19 costs                                                                    17.3                7.4

Inventory write-downs from restructuring                                           4.2               29.3
Restructuring and asset impairment charges                                        16.6               68.5

  Goodwill impairment                                                             52.8               34.6

Adjusted operating (loss) income excluding special items                     $  (105.5)         $   166.9

Operating margin                                                                 (16.8) %             1.2  %

Adjusted operating margin excluding surcharge revenue and special
items                                                                             (8.4) %             9.1  %



                                       27

--------------------------------------------------------------------------------
  Table of Contents
Interest Expense, Net and Debt Extinguishment Losses, Net

Fiscal year 2021 interest expense, net was $32.7 million compared to $19.8
million in fiscal year 2020. We have historically used interest rate swaps to
achieve a level of floating rate debt to fixed rate debt where appropriate; all
interest rate swaps were terminated as of September 30, 2020 in connection with
the prepayment of the related $250.0 million notes. Interest expense, net for
fiscal year 2021 includes net gains from interest rate swaps of $0.4 million
compared with $1.4 million of net gains from interest rate swaps for fiscal year
2020. Capitalized interest reduced interest expense by $8.1 million for fiscal
year 2021 and by $9.0 million in fiscal year 2020. Debt extinguishment losses,
net in fiscal year 2021 include $10.5 million of debt prepayment costs on the
notes due July 2021 partially offset by gains of $2.3 million on the related
interest rate swaps that were terminated in connection with the prepayment.

Other Expense (Income), Net



Other expense for fiscal year 2021 was $8.4 million compared with other income
of $0.6 million a year ago. The fiscal year 2021 expense is primarily due to
pension settlement charges of $11.4 million. There were no pension settlement
charges in fiscal year 2020.

Income Taxes



Our effective tax rate (income tax (benefit) expense as a percent of (loss)
income before taxes) for fiscal year 2021 was 22.9 percent as compared to 75.4
percent for fiscal year 2020. The fiscal year 2021 tax benefit includes the
unfavorable impacts of the $52.8 million non-deductible goodwill impairment
charge and losses in certain foreign jurisdictions for which no tax benefit can
be recognized, as well as, tax benefits of $2.8 million associated with pension
settlement charges, $2.0 million associated with debt extinguishment losses,
net, $5.0 million for the impact of restructuring and asset impairment charges
and $0.7 million as a result of changes in our prior year tax positions.
Additionally, the anticipated benefit for the carryback of the current year net
operating loss to fiscal years with higher tax rates is included in the period.
Also included is a tax charge of $1.4 million attributable to employee
share-based compensation. Excluding the tax impact of the non-deductible
goodwill impairment charge, pension settlement charges, debt extinguishment
losses, net restructuring and asset impairment charges and changes in our prior
year tax positions, the tax rate for fiscal year 2021 would have been 28.2
percent. The fiscal year 2020 tax expense includes the unfavorable impact of the
$10.7 million non-deductible goodwill impairment charge and losses in certain
foreign jurisdictions for which no tax benefit can be recognized, as well as,
tax benefits of $27.0 million for the impact of restructuring and asset
impairment charges and $1.0 million as a result of changes in our prior year tax
positions. Excluding the impact of the non-deductible goodwill impairment
charge, restructuring and asset impairment charges and changes in the our prior
year tax positions, the tax rate for fiscal year 2020 would have been 23.6
percent.

The Coronavirus Aid, Relief and Economic Security Act (the "CARES Act") was
enacted on March 27, 2020. The CARES Act established new provisions, including
but not limited to, expanded deduction of certain qualified capital
expenditures, delayed payment of certain employment taxes, expanded use of net
operating losses, reduced limitations on deductions of interest expense and
extension of funding for defined benefit plans. The net operating loss provision
is expected to provide incremental tax benefits of approximately $7.0 million
due to the higher tax rates in the expanded carryback period. The other
provisions in the CARES Act are not expected to have a significant impact on our
financial position, results of operations or cash flows.

Undistributed earnings of our foreign subsidiaries, totaling $56.4 million were
considered permanently reinvested. If these earnings were to be repatriated,
approximately $0.8 million of tax expense would be incurred.

See Note 18 to the consolidated financial statements in Item 8. "Financial Statements and Supplementary Data" for a full reconciliation of the statutory federal tax rate to the effective tax rates.


                                       28
--------------------------------------------------------------------------------
  Table of Contents
Business Segment Results

Summary information about our operating results on a segment basis is set forth
below. For more detailed segment information, see Note 20 to the consolidated
financial statements included in Item 8. "Financial Statements and Supplementary
Data".

The following table includes comparative information for volumes by business
segment:

                                                 Fiscal Year                     $                %
(Pounds sold, in thousands)                2021                 2020         (Decrease)       (Decrease)
Specialty Alloys Operations             166,942               221,784       (54,842)               (25) %
Performance Engineered Products *         7,936                12,260        (4,324)               (35) %
Intersegment                             (5,172)               (2,308)       (2,864)              (124) %
Consolidated pounds sold                169,706               231,736       (62,030)               (27) %


* Pounds sold data for PEP segment includes Dynamet and Additive businesses only.



The following table includes comparative information for net sales by business
segment:

                                            Fiscal Year                  $               %
                                                                    (Decrease)       (Decrease)
($ in millions)                         2021           2020          Increase         Increase
Specialty Alloys Operations          $ 1,262.2      $ 1,831.6      $    (569.4)           (31) %
Performance Engineered Products          259.8          401.1           (141.3)           (35) %
Intersegment                             (46.4)         (51.6)             5.2             10  %
Total net sales                      $ 1,475.6      $ 2,181.1      $    (705.5)           (32) %


The following table includes comparative information for our net sales by business segment, but excluding surcharge revenue:



                                                                   Fiscal Year                       $                       %
                                                                                                 (Decrease)              (Decrease)
($ in millions)                                              2021               2020              Increase                Increase
Specialty Alloys Operations                              $ 1,042.8          $ 1,483.0          $    (440.2)                       (30) %
Performance Engineered Products                              255.9              395.2               (139.3)                       (35) %
Intersegment                                                 (45.9)             (49.5)                 3.6                          7  %
Total net sales excluding surcharge revenue              $ 1,252.8          $ 1,828.7          $    (575.9)                       (31) %



Specialty Alloys Operations Segment



Net sales in fiscal year 2021 for the SAO segment decreased 31 percent to
$1,262.2 million, as compared with $1,831.6 million in fiscal year 2020.
Excluding surcharge revenue, net sales decreased 30 percent from a year ago. The
fiscal year 2021 net sales reflected 25 percent lower shipment volume as
compared to fiscal year 2020. The SAO segment results reflect lower sales in the
Aerospace and Defense and Medical end-use markets compared to the prior year
caused by the market impact from the COVID-19 pandemic. Sales in the
Transportation end-use market increased in fiscal year 2021 compared to fiscal
year 2020.

Operating loss for the SAO segment in fiscal year 2021 was $87.4 million, or
negative 6.9 percent of net sales (negative 8.4 percent of net sales excluding
surcharge revenue), compared to operating income of $239.0 million, or 13.0
percent of net sales (16.1 percent of net sales excluding surcharge revenue),
for fiscal year 2020. Fiscal year 2021 included LIFO decrement charges of $47.9
million compared to $1.8 million in fiscal year 2020. The LIFO decrement charges
are non-cash charges associated with reducing inventory and liquidating LIFO
layers that have historical costs in excess of the current year inventory costs.
The fiscal year 2021 results also include $14.6 million of COVID-19 related
costs compared to $6.5 million in fiscal year 2020.
                                       29
--------------------------------------------------------------------------------
  Table of Contents
Performance Engineered Products Segment

Net sales for fiscal year 2021 for the PEP segment were $259.8 million as
compared with $401.1 million for fiscal year 2020. Excluding surcharge revenue,
net sales decreased 35 percent from a year ago. The results reflect decreases in
sales in all end-use markets. This included lower demand in the Medical end-use
market from delays in elective procedures caused by COVID-19. The current year
net sales results reflect the divestiture of the Amega West business on
September 30, 2020.

Operating loss for the PEP segment for fiscal year 2021 was $16.5 million, or
negative 6.4 percent of net sales, as compared with operating loss of $10.4
million, or negative 2.6 percent of net sales for fiscal year 2020. Fiscal year
2021 included LIFO decrement charges of $4.3 million. The LIFO decrement charges
are non-cash charges associated with reducing inventory and liquidating LIFO
layers that have historical costs in excess of the current year inventory costs.
The fiscal year 2021 results also include $2.7 million of COVID-19 related costs
compared to $0.9 million in fiscal year 2020.

Results of Operations - Fiscal Year 2020 Compared to Fiscal Year 2019



For fiscal year 2020, we reported net income of $1.5 million, or $0.02 per
diluted share. Excluding special items, earnings per share would have been $2.36
per diluted share for fiscal year 2020. This compared to net income of $167.0
million, or $3.43 per diluted share, for fiscal year 2019. Excluding special
items, earnings per share would have been $3.46 per diluted share for fiscal
year 2019. Our fiscal year 2020 results reflect goodwill impairment charges
totaling $34.6 million and inventory write-downs and restructuring and asset
impairment charges of $97.8 million.
Net Sales

Net sales for fiscal year 2020 were $2,181.1 million, which was an 8 percent
decrease from fiscal year 2019. Excluding surcharge revenue, sales were 6
percent lower than fiscal year 2019 on 13 percent lower volume. The results
reflect higher demand and better mix during the first half of fiscal year 2020.
This improvement was negated in the second half of fiscal year 2020 by the
financial disruptions caused by COVID-19, resulting in lower demand across all
end-use markets versus the prior year period.

Geographically, sales outside the United States increased 2 percent from fiscal
year 2019 to $787.7 million. The increase is primarily due to stronger product
demand in the Aerospace and Defense end-use market in Asia Pacific, Europe and
Canada which was partially offset by lower demand in the Consumer and Industrial
end-use market in Europe. A portion of our sales outside the United States are
denominated in foreign currencies. The impact of fluctuations in foreign
currency exchange rates resulted in a $3.5 million decrease in sales during
fiscal year 2020 compared to fiscal year 2019. International sales as a
percentage of our total net sales represented 36 percent and 32 percent for
fiscal year 2020 and fiscal year 2019, respectively.

Sales by End-Use Markets



We sell to customers across diversified end-use markets. The following table
includes comparative information for our net sales, which includes surcharge
revenue, by principal end-use markets. We believe this is helpful supplemental
information in analyzing performance of the business from period to period.
                                    Fiscal Year                $             %
($ in millions)                 2020           2019         Decrease      Decrease
Aerospace and Defense        $ 1,313.7      $ 1,327.9      $  (14.2)          (1) %
Medical                          197.0          205.0          (8.0)          (4) %
Transportation                   132.1          157.7         (25.6)         (16) %
Energy                           135.4          181.7         (46.3)         (25) %
Industrial and Consumer          296.0          371.5         (75.5)         (20) %
Distribution                     106.9          136.4         (29.5)         (22) %
Total net sales              $ 2,181.1      $ 2,380.2      $ (199.1)          (8) %


                                       30

--------------------------------------------------------------------------------
  Table of Contents
The following table includes comparative information for our net sales by the
same principal end-use markets, but excluding surcharge revenue:


                                                                  Fiscal Year                       $                       %
                                                                                                 Increase                Increase
($ in millions)                                             2020               2019             (Decrease)              (Decrease)

Aerospace and Defense                                   $ 1,072.1          $ 1,051.5          $      20.6                          2  %
Medical                                                     177.2              176.3                  0.9                          1  %
Transportation                                              108.7              126.6                (17.9)                       (14) %
Energy                                                      116.4              154.3                (37.9)                       (25) %
Industrial and Consumer                                     248.1              298.5                (50.4)                       (17) %
Distribution                                                106.2              134.9                (28.7)                       (21) %
Total net sales excluding surcharge revenue             $ 1,828.7          $ 1,942.1          $    (113.4)                        (6) %



Sales to the Aerospace and Defense market decreased 1 percent from fiscal
year 2019 to $1,313.7 million. Excluding surcharge revenue, sales
increased 2 percent on 4 percent lower shipment volume. The results reflect
stronger demand for materials used across all aerospace sub-markets and defense
during the first half of the current fiscal year offset by lower build rates
caused by the global travel halt in the second half of fiscal year 2020 due to
the COVID-19 pandemic.

Sales to the Medical market decreased 4 percent to $197.0 million from fiscal year 2019. Excluding surcharge revenue, sales increased 1 percent on 5 percent lower shipment volume. The results reflect the impact of temporary delays of elective medical procedures from the COVID-19 pandemic during the second half of fiscal year 2020 compared to the prior year period.



Transportation market sales of $132.1 reflected a 16 percent decrease from
fiscal year 2019. Excluding surcharge revenue, sales decreased 14 percent
on 20 percent lower shipment volume. The results reflect decreased demand caused
by COVID-19 related plant closures and production disruptions in North America,
Asia and Europe in the second half of fiscal year 2020.

Sales to the Energy market of $135.4 million reflected a 25 percent decrease from fiscal year 2019. Excluding surcharge revenue, sales decreased 25 percent. The results reflect the decreasing demand globally including a 60 percent decrease in North America rig counts.



Industrial and Consumer market sales decreased 20 percent to $296.0 million for
fiscal year 2020. Excluding surcharge revenue, sales decreased 17 percent on 26
percent lower shipment volume. The results reflect the impact of reduced demand
for materials used in select industrial applications and declines in demand for
consumer electronics and sporting goods.

Gross Profit



Gross profit in fiscal year 2020 decreased to $329.4 million, or 15.1 percent of
net sales from $444.8 million, or 18.7 percent of net sales for fiscal
year 2019. During the fiscal year ended June 30, 2020 we recorded $1.8 million
of LIFO decrement charges and $29.3 million of inventory write-downs related to
targeted cost reduction actions including exiting the oil and gas business in
our PEP segment and the closure of two powder facilities. Fiscal year 2020
results were impacted by the COVID-19 pandemic and the 737 MAX production halt.
Fiscal year 2020 results were also negatively impacted by an accelerated
inventory reduction program.

Excluding the impact of the surcharge revenue, LIFO decrement and the inventory
write-downs, our gross margin in fiscal year 2020 was 19.7 percent compared to
22.9 percent in fiscal year 2019. The results reflect the impact of improved
product mix and capacity gains during the first half of fiscal year 2020 offset
by incremental costs and productivity losses due to COVID-19. Fiscal year 2019
also reflects an $11.4 million benefit related to an insurance recovery in our
third fiscal quarter of fiscal year 2019.

Our surcharge mechanism is structured to recover increases in raw material
costs, although in certain cases with a lag effect as discussed above. While the
surcharge generally protects the absolute gross profit dollars, it does have a
dilutive effect on gross margin as a percent of sales. The following represents
a summary of the dilutive impact of the surcharge on gross margin. We present
and discuss these financial measures because management believes removing the
impact of surcharge provides a more consistent and meaningful basis for
comparing results of operations from period to period. See the section "Non-GAAP
Financial Measures" below for further discussion of these financial measures.
                                       31

--------------------------------------------------------------------------------


  Table of Contents
                                                                        Fiscal Year
($ in millions)                                                     2020            2019
Net sales                                                       $ 2,181.1       $ 2,380.2
Less: surcharge revenue                                             352.4           438.1
Net sales excluding surcharge revenue                           $ 1,828.7       $ 1,942.1

Gross profit                                                    $   329.4       $   444.8

LIFO decrement                                                        1.8               -
Inventory write-downs from restructuring                             29.3               -
Gross profit excluding special items                            $   360.5       $   444.8

Gross margin                                                         15.1  %         18.7  %

Gross margin excluding surcharge revenue and special items           19.7  

% 22.9 %

Selling, General and Administrative Expenses



Selling, general and administrative expenses in fiscal year 2020 were $201.0
million, or 9.2 percent of net sales (11.0 percent of net sales excluding
surcharge revenue), compared to $203.4.million, or 8.5 percent of net sales
(10.5 percent of net sales excluding surcharge revenue), in fiscal year 2019.
Selling, general and administrative expenses were relatively flat in fiscal year
2020 compared to fiscal year 2019. Fiscal year 2020 results reflect lower salary
costs and variable compensation expense offset by higher spending in key growth
areas including additive manufacturing compared to the same period a year ago.

Restructuring and Asset Impairment Charges



During fiscal year 2020, we incurred $68.5 million of restructuring and asset
impairment charges. This included $56.4 million of non-cash impairment charges
to write down property, plant and equipment and other intangible assets
primarily related to the exit from the oil and gas business and the closure of
two domestic powder facilities. The remaining $12.1 million, consisting
primarily of various personnel-related costs for severance payments, medical
coverage and related items, resulted from a restructuring plan to reduce the
global salaried workforce by twenty percent. No restructuring or asset
impairment charges were incurred during the fiscal year ended June 30, 2019.

Activities undertaken in connection with the fiscal year 2020 restructuring plan were substantially complete in the first quarter of fiscal year 2021.

Goodwill Impairment Charge



Our long-term projections for the Additive reporting unit within the PEP Segment
have been impacted by slower than expected growth in additive manufacturing
applications which was further compounded by the effects from COVID-19. As a
result, during fiscal year 2020 we recorded an impairment charge of $34.6
million, which represented a portion of the balance of the goodwill recorded for
this reporting unit. No goodwill impairment charges were incurred during the
fiscal year ended June 30, 2019.

                                       32
--------------------------------------------------------------------------------
  Table of Contents
Operating Income

Our operating income in fiscal year 2020 decreased to $25.3 million,
or 1.2 percent of net sales as compared with $241.4 million, or 10.1 percent of
net sales in fiscal year 2019. Excluding surcharge revenue and special items,
adjusted operating margin was 9.1 percent for fiscal year 2020 and 12.5 percent
for fiscal year 2019. The second half of fiscal year 2020 was negatively
impacted by the financial disruptions of COVID-19 and the Boeing 737 MAX
production halt compared to fiscal year 2019. During this time, we executed
targeted cost reduction actions and portfolio restructurings including exiting
the oil and gas business in our PEP segment, closure of two domestic powder
facilities, global salaried workforce reductions and other asset impairments.
These actions resulted in LIFO decrement charges of $1.8 million, COVID-19 costs
of $7.4 million, inventory write-downs of $29.3 million and restructuring and
asset impairment charges of $68.5 million in fiscal year 2020. Operating income
in fiscal year 2020 was also impacted by a goodwill impairment charge of $34.6
million.

The following presents our operating income and operating margin, in each case
excluding the impact of surcharge on net sales and excluding special items. We
present and discuss these financial measures because management believes
removing the impact of these items provides a more consistent and meaningful
basis for comparing results of operations from period to period. See the section
"Non-GAAP Financial Measures" below for further discussion of these financial
measures.

                                                                                            Fiscal Year
($ in millions)                                                                       2020               2019
Net sales                                                                         $ 2,181.1          $ 2,380.2
Less: surcharge revenue                                                               352.4              438.1
Net sales excluding surcharge revenue                                             $ 1,828.7          $ 1,942.1

Operating income                                                                  $    25.3          $   241.4

Special items:
LIFO decrement                                                                          1.8                  -
COVID-19 costs                                                                          7.4                  -

 Inventory write-downs from restructuring                                              29.3                  -
 Acquisition-related costs                                                                -                1.2
 Restructuring and asset impairment charges                                            68.5                  -
 Goodwill impairment                                                                   34.6                  -
Adjusted operating income excluding special items                                 $   166.9          $   242.6

Operating margin                                                                        1.2  %            10.1  %

Adjusted operating margin excluding surcharge revenue and special items


            9.1  %            12.5  %


Interest Expense

Fiscal year 2020 interest expense was $19.8 million compared to $26.0 million in
fiscal year 2019. We have used interest rate swaps to achieve a level of
floating rate debt to fixed rate debt. Interest expense for fiscal year 2020
includes net gains from interest rate swaps of $1.4 million compared with $0.2
million of net losses from interest rate swaps for fiscal year 2019. Capitalized
interest reduced interest expense by $9.0 million for fiscal year 2020 compared
to $5.1 million in fiscal year 2019.

Other Income, Net

Other income for fiscal year 2020 of $0.6 million was consistent with other income of $0.6 million in fiscal year 2019.


                                       33

--------------------------------------------------------------------------------

Table of Contents

Income Taxes



Our effective tax rate (income tax expense as a percent of income before taxes)
for fiscal year 2020 was 75.4 percent as compared to 22.7 percent for fiscal
year 2019. The fiscal year 2020 tax expense includes tax benefits of $1.0
million as a result of changes in our prior tax positions as well as a $2.0
million charge for non-deductible goodwill impairment. The effective tax rate
for fiscal year 2020 as compared to 2019 reflects the magnified impact of
permanent adjustments on a significantly lower pre-tax income.

Fiscal year 2019 income tax expense includes tax benefits of $1.8 million as a result of changes in our prior year tax positions.



The Coronavirus Aid, Relief and Economic Security Act (the "CARES Act") was
enacted on March 27, 2020. The CARES Act established new provisions, including
but not limited to, expanded deduction of certain qualified capital
expenditures, delayed payment of certain employment taxes, expanded use of net
operating losses, reduced limitations on deductions of interest expense and
extension of funding for defined benefit plans. We are continuing to evaluate
these provisions but do not anticipate the CARES Act will have a significant
impact on our financial position, results of operations or cash flows.

The Tax Cuts and Jobs Act was enacted on December 22, 2017. The Tax Cuts and
Jobs Act included provisions that reduced the federal corporate income tax rate,
created a territorial tax system with a one-time mandatory tax on previously
deferred foreign earnings (i.e. transition tax), and changed certain business
deductions including allowing for immediate expensing of certain qualified
capital expenditures and limitation on deductions of interest expense. During
fiscal year 2019, we recorded a discrete tax benefit of $0.2 million for the
transition tax offset by a discrete tax charge of $0.2 million for the
re-measurement of deferred tax assets and liabilities. The accounting for the
income tax effects of the Tax Cuts and Jobs Act was completed by December 31,
2018. Under the Tax Cuts and Jobs Act the transition tax is being paid over an
eight year period beginning in fiscal year 2019.

Undistributed earnings of our foreign subsidiaries, totaling $61.7 million were
considered permanently reinvested. Following enactment of the Act, the
repatriation of cash to the U.S. is generally no longer taxable for federal
income tax purposes. If these earnings were to be repatriated, approximately
$0.1 million of tax expense would be incurred.

See Note 18 to the consolidated financial statements in Item 8. "Financial
Statements and Supplementary Data"
for a full reconciliation of the statutory federal tax rate to the effective tax
rates.

Business Segment Results

Summary information about our operating results on a segment basis is set forth
below. For more detailed segment information, see Note 20 to the consolidated
financial statements included in Item 8. "Financial Statements and Supplementary
Data".

 The following table includes comparative information for volumes by business
segment:

                                                                                         Fiscal Year                                 $                            %
(Pounds sold, in thousands)                                                     2020                     2019               (Decrease) Increase          (Decrease) Increase
Specialty Alloys Operations                                                    221,784                   256,360                  (34,576)                             (13) %
Performance Engineered Products *                                               12,260                    13,752                   (1,492)                             (11) %
Intersegment                                                                    (2,308)                   (2,576)                     268                               10  %
Consolidated pounds sold                                                       231,736                   267,536                  (35,800)                             (13) %


* Pounds sold data for PEP segment includes Dynamet, Carpenter Powder Products and Additive businesses only.


                                       34
--------------------------------------------------------------------------------
  Table of Contents
The following table includes comparative information for net sales by business
segment:


                                                                   Fiscal Year                        $
                                                                                                 (Decrease)                   %
($ in millions)                                              2020               2019              Increase           (Decrease) Increase
Specialty Alloys Operations                              $ 1,831.6          $ 1,967.3          $     (135.7)                        (7) %
Performance Engineered Products                              401.1              479.8                 (78.7)                       (16) %
Intersegment                                                 (51.6)             (66.9)                 15.3                         23  %
Total net sales                                          $ 2,181.1          $ 2,380.2          $     (199.1)                        (8) %


The following table includes comparative information for our net sales by business segment, but excluding surcharge revenue:




                                                                  Fiscal Year                        $
                                                                                                (Decrease)                   %
($ in millions)                                             2020               2019              Increase           (Decrease) Increase
Specialty Alloys Operations                             $ 1,483.0          $ 1,536.6          $      (53.6)                        (3) %
Performance Engineered Products                             395.2              467.0                 (71.8)                       (15) %
Intersegment                                                (49.5)             (61.5)                 12.0                         20  %
Total net sales excluding surcharge revenue             $ 1,828.7          $ 1,942.1          $     (113.4)                        (6) %



Specialty Alloys Operations Segment



Net sales in fiscal year 2020 for the SAO segment decreased 7 percent
to $1,831.6 million, as compared with $1,967.3 million in fiscal year 2019.
Excluding surcharge revenue, net sales decreased 3 percent from fiscal year
2019. The fiscal year 2020 net sales reflected 13 percent lower shipment volume
as compared to fiscal year 2019. The SAO segment results reflect higher sales
and stronger product mix in key end-use markets during the first half of fiscal
year 2020 offset by the impacts of the 737 MAX production halt and the COVID-19
pandemic during the second half of fiscal year 2020.

Operating income for the SAO segment in fiscal year 2020 was $239.0 million,
or 13.0 percent of net sales (16.1 percent of net sales excluding surcharge
revenue), compared to $282.2 million, or 14.3 percent of net sales (18.4 percent
of net sales excluding surcharge revenue), for fiscal year 2019. The decrease in
operating income reflects productivity losses and impacts from an accelerated
inventory reduction program in the second half of the current fiscal year due to
the COVID-19 pandemic. This was partially offset by the impact of the higher
valued product mix and demand in our premium products during the first half of
fiscal year 2020.

Performance Engineered Products Segment



Net sales for fiscal year 2020 for the PEP segment were $401.1 million as
compared with $479.8 million for fiscal year 2019. Excluding surcharge revenue,
net sales decreased 15 percent from fiscal year 2019. The results reflect
decreases in sales in all end-use markets except the Medical end-use market.
Prolonged weakness in the oil and gas sub-market and impacts of tariffs were the
primary drivers for the Energy and Distribution end-use market declines,
respectively.

Operating loss for the PEP segment for fiscal year 2020 was $10.4 million,
or 2.6 percent of net sales, as compared with operating income of $30.0 million,
or 6.3 percent of net sales for fiscal year 2019. Fiscal year 2020 results were
impacted by weak demand in the oil and gas sub-market, the ongoing trade actions
and tariffs on our distribution business and the impacts of COVID-19. The prior
year results were impacted by an $11.4 million benefit related to an insurance
recovery. During fiscal year 2020 we approved a plan to exit the oil and gas
business in our PEP segment and close two domestic powder facilities.
                                       35

--------------------------------------------------------------------------------

Table of Contents

Liquidity and Financial Resources



During fiscal year 2021, we generated cash from operating activities of $250.0
million as compared with $231.8 million in fiscal year 2020. Our free cash flow,
which we define under "Non-GAAP Financial Measures" below, was positive $132.0
million as compared to positive $21.8 million for the same period a year ago.
The change in operating cash flow primarily reflects the impact of lower
earnings after non-cash adjustments to net income in fiscal year 2021 offset by
improvements in working capital compared to a year ago. The current year
reflects impacts from targeted inventory reductions to strengthen liquidity.
Cash generated from reductions in inventory was $238.5 million and $29.5 million
in fiscal years 2021 and 2020, respectively. During the year ended June 30,
2021, we generated cash from accounts payable of $22.4 million compared to the
use of cash of $109.9 million in the same period a year ago. The free cash flow
results reflect lower capital spending levels in the current period as compared
to the prior year period. Fiscal year 2021 results also include $20.0 million of
proceeds related to the sale of our Amega West business.

Capital expenditures for property, plant, equipment and software were $100.5
million for fiscal year 2021 as compared to $171.4 million for fiscal year 2020.
In fiscal year 2022, we expect capital expenditures to be approximately $125
million.

We evaluate liquidity needs for alternative uses including funding external
growth opportunities, share repurchases as well as funding consistent dividend
payments to stockholders. Dividends for fiscal year 2021 were $39.1 million, as
compared to $38.8 million in the prior year period. In fiscal years 2021, 2020
and 2019 we declared and paid quarterly cash dividends of $0.20 per share.

For the fiscal years ended June 30, 2021, 2020 and 2019, interest costs totaled
$40.8 million, $28.8 million and $31.1 million, respectively, of which $8.1
million, $9.0 million and $5.1 million, respectively, were capitalized as part
of the cost of property, plant, equipment and software. Debt extinguishment
losses, net for the year ended June 30, 2021 includes $10.5 million of debt
prepayment costs on notes due July 2021, offset by gains of $2.3 million on
related interest rate swaps that were terminated in connection with the
prepayment. For the years ended June 30, 2020 and 2019, there were no debt
extinguishment losses, net.

During fiscal year 2021, we made required minimum pension contributions of $19.9
million in total to three of our qualified pension plans. We are not required to
make cash contributions to our qualified pension plans during fiscal year 2022
as a result of the American Rescue Plan Act of 2021. Over the next five years,
current estimates indicate that we will be required to make approximately $5.7
million of cash contributions to our pension plans, based on the laws in effect
for pension funding as of June 30, 2021, and subject to market returns and
interest rate assumptions.

We have demonstrated the ability to generate cash to meet our needs through cash
flows from operations, management of working capital and the ability to access
capital markets to supplement internally generated funds. We target minimum
liquidity of $150 million, consisting of cash and cash equivalents added to
available borrowing capacity under our Credit Facility.

On March 26, 2021, we entered into our $300.0 million secured revolving Credit
Facility. The Credit Facility amended and restated the previous revolving credit
facility, dated March 31, 2017, which had been set to expire in March 2022. The
Credit Facility made several changes from the prior Credit Agreement. The Credit
Facility extends the maturity to March 31, 2024, subject to a springing maturity
of November 30, 2022. If, by November 30, 2022, our outstanding $300.0 million
4.45 percent Senior Notes due in March 2023 are not redeemed, repurchased or
refinanced with indebtedness having a maturity date of October 1, 2024 or later,
all indebtedness under the Credit Facility will be due. The Credit Facility
contains a revolving credit commitment amount of $300.0 million, subject to our
right, from time to time, to request an increase of the commitment to
$500.0 million in the aggregate; and provides for the issuance of letters of
credit subject to a $40.0 million sub-limit. We have the right to voluntarily
prepay and re-borrow loans, to terminate or reduce the commitments under the
Credit Facility, and, subject to certain lender approvals, to join subsidiaries
as subsidiary borrowers.

As of June 30, 2021, we had $5.4 million of issued letters of credit and no
short-term borrowings under the Credit Facility. The balance of the Credit
Agreement, $294.6 million, remains available to us. From time to time during the
year ended June 30, 2021, we have borrowed under our Credit Facility. The
weighted average daily borrowing under the Credit Facility during the fiscal
year ended June 30, 2021 was approximately $13.0 million with daily outstanding
borrowings ranging from $0.0 million to $170.0 million. As of June 30, 2021, the
borrowing rate for the Credit Facility was 2.10 percent.

                                       36

--------------------------------------------------------------------------------

Table of Contents We believe that our total liquidity of $582.0 million, as of June 30, 2021, which includes cash and cash equivalents of $287.4 million and available borrowing capacity of $294.6 million under our credit facility, will be sufficient to fund our cash needs over the foreseeable future.



As of June 30, 2021, we had cash and cash equivalents of approximately $44.0
million held at various foreign subsidiaries. Our global cash deployment
considers, among other things, the geographic location of our subsidiaries' cash
balances, the locations of our anticipated liquidity needs and the cost to
access international cash balances, as necessary. During the fiscal year ended
June 30, 2021, we repatriated cash of $11.4 million from foreign jurisdictions.

We are subject to certain financial and restrictive covenants under the Credit
Facility, which, among other things, require the maintenance of a minimum
interest coverage ratio. The interest coverage ratio is defined in the Credit
Facility as, for any period, the ratio of consolidated earnings before interest,
taxes, depreciation and amortization and non-cash net pension expense ("EBITDA")
to consolidated interest expense for such period. The interest coverage covenant
is waived until the quarter ended March 31, 2022 at which time it will be 3.00
to 1.00 and then 3.50 to 1.00 thereafter. The Credit Facility also requires us
to maintain a debt to capital ratio of less than 55 percent. The debt to capital
ratio is defined in the Credit Facility as the ratio of consolidated
indebtedness, as defined therein, to consolidated capitalization, as defined
therein. During the period in which the interest coverage covenant is waived,
the Credit Facility requires that we maintain a minimum available liquidity of
$150.0 million which is defined in the Credit Facility as the aggregate amount
of loans available to be drawn under the facility plus non-restricted cash and
cash equivalents as defined therein. In addition, we are subject to an asset
coverage ratio minimum of 1.10 to 1.00. The asset coverage ratio is defined in
the Credit Facility as eligible receivables and inventory, as defined therein,
to outstanding loans and obligations, as defined therein. As of June 30, 2021,
we were in compliance with all of the covenants of the Credit Facility.

The following table shows our actual ratio performance with respect to the financial covenants, as of June 30, 2021:



                                                                                                           Actual
Covenant                                                           Covenant Requirement                    Ratio
Consolidated debt to capital                                          55% (maximum)                         33%
Available liquidity (excludes certain foreign cash)                  $150.0 (minimum)                  $543.0 million
Asset coverage ratio                                                   1.10 to 1.00                    60.67 to 1.00

To the extent that we do not comply with the current or modified covenants under the Credit Facility, this could reduce our liquidity and flexibility due to potential restrictions on borrowings available to us unless we are able to obtain waivers or modifications of the covenants.

Non-GAAP Financial Measures

The following provides additional information regarding certain non-GAAP financial measures that we use in this report. Our definitions and calculations of these items may not necessarily be the same as those used by other companies.

Net Sales and Gross Margin Excluding Surcharge Revenue and Special Items



This report includes discussions of net sales as adjusted to exclude the impact
of raw material surcharge and special items and the resulting impact on gross
margins, which represent financial measures that have not been determined in
accordance with accounting principles generally accepted in the United States of
America ("U.S. GAAP"). We present and discuss these financial measures because
management believes removing the impact of raw material surcharge from net sales
provides a more consistent basis for comparing results of operations from period
to period for the reasons discussed earlier in this report. In addition,
management believes that excluding the inventory write-downs from gross profit
and gross margin is helpful in analyzing our operating performance as the
inventory write-downs from restructuring are not indicative of ongoing operating
performance. Management uses its results excluding these amounts to evaluate its
operating performance and to discuss its business with investment institutions,
our board of directors and others. See our earlier discussion of "Gross Profit"
for a reconciliation of net sales and gross margin, excluding surcharge revenue
and special items, to net sales as determined in accordance with U.S. GAAP. Net
sales and gross margin excluding surcharge revenue and special items is not a
U.S. GAAP financial measure and should not be considered in isolation of, or as
a substitute for, net sales and gross margin calculated in accordance with U.S.
GAAP.

                                       37

--------------------------------------------------------------------------------

Table of Contents Adjusted Operating (Loss) Income and Adjusted Operating Margin Excluding Surcharge Revenue and Special Items



This report includes discussions of operating (loss) income and operating margin
as adjusted to exclude the impact of raw material surcharge revenue and special
items which represent financial measures that have not been determined in
accordance with U.S. GAAP. We present and discuss these financial measures
because management believes removing the impact of raw material surcharge from
net sales provides a more consistent and meaningful basis for comparing results
of operations from period to period for the reasons discussed earlier in this
report. In addition, management believes that excluding special items from
operating margin is helpful in analyzing our operating performance, as these
items are not indicative of ongoing operating performance. Management uses its
results excluding these amounts to evaluate its operating performance and to
discuss its business with investment institutions, our board of directors and
others. See our earlier discussion of operating (loss) income for a
reconciliation of adjusted operating (loss) income and adjusted operating margin
excluding special items to operating (loss) income and operating margin
determined in accordance with U.S. GAAP. Adjusted operating (loss) income and
adjusted operating margin excluding surcharge revenue and special items is not a
U.S. GAAP financial measure and should not be considered in isolation of, or as
a substitute for, operating (loss) income and operating margin calculated in
accordance with U.S. GAAP.

Adjusted (Loss) Earnings Per Share

The following provides a reconciliation of adjusted (loss) earnings per share, to its most directly comparable U.S. GAAP financial measures:



                                                  Loss Before           Income Tax                               Loss Per
($ in millions, except per share data)            Income Taxes           Benefit             Net Loss         Diluted Share*
Year ended June 30, 2021, as reported            $    (297.9)         $      68.3          $  (229.6)         $      (4.76)

Special items:
 LIFO decrement                                         52.2                (14.9)              37.3                  0.77
 COVID-19 costs                                         17.3                 (5.0)              12.3                  0.25
 Inventory write-downs from restructuring                4.2                 (1.0)               3.2                  0.07
 Restructuring and asset impairment
charges                                                 16.6                 (4.0)              12.6                  0.26
 Goodwill impairment                                    52.8                 (0.1)              52.7                  1.09
 Debt extinguishment losses, net                         8.2                 (2.0)               6.2                  0.13
 Pension settlement charges                             11.4                 (2.8)               8.6                  0.18
Total impact of special items                          162.7                (29.8)             132.9                  2.75

Year ended June 30, 2021, as adjusted            $    (135.2)         $     

38.5 $ (96.7) $ (2.01)

* Impact per diluted share calculated using weighted average common shares outstanding of 48.3 million for the fiscal year ended June 30, 2021.


                                       38

--------------------------------------------------------------------------------

Table of Contents


                                                 Income Before         Income Tax                                Earnings Per
($ in millions, except per share data)           Income Taxes            Expense            Net Income          Diluted Share*
Year ended June 30, 2020, as reported           $        6.1          $     (4.6)         $       1.5          $        0.02

Special items:
LIFO decrement                                           1.8                (0.4)                 1.4                   0.03
COVID-19 costs                                           7.4                (1.5)                 5.9                   0.12
Inventory write-downs from restructuring                29.3                (6.0)                23.3                   0.49
Restructuring and asset impairment
charges                                                 68.5               (14.0)                54.5                   1.13
Goodwill impairment                                     34.6                (7.1)                27.5                   0.57
Total impact of special items                          141.6               (29.0)               112.6                   2.34

Year ended June 30, 2020, as adjusted           $      147.7          $    

(33.6) $ 114.1 $ 2.36

* Impact per diluted share calculated using weighted average common shares outstanding of 48.2 million for the fiscal year ended June 30, 2020.



Management believes that the presentation of (loss) earnings per share adjusted
to exclude the impact of special items is helpful in analyzing the operating
performance of the Company, as these items are not indicative of ongoing
operating performance. Management uses its results excluding these amounts to
evaluate its operating performance and to discuss its business with investment
institutions, the Company's board of directors and others. Our definitions and
calculations of these items may not necessarily be the same as those used by
other companies. Adjusted (loss) earnings per share is not a U.S. GAAP financial
measure and should not be considered in isolation of, or as a substitute for,
(loss) earnings per share calculated in accordance with U.S. GAAP.

Free Cash Flow



The following provides a reconciliation of free cash flow, as used in this
annual report, to its most directly comparable U.S. GAAP financial measures:
                                                                                     Fiscal Year
($ in millions)                                                       2021               2020               2019
Net cash provided from operating activities                       $   250.0          $   231.8          $   232.4
Purchases of property, plant, equipment and software                 (100.5)            (171.4)            (180.3)
Acquisition of business, net of cash acquired                             -                  -              (79.0)

Proceeds from disposals of property, plant and equipment and assets held for sale

                                                1.6                0.2                0.4
Proceeds from divestiture of business                                  20.0                  -                  -
Proceeds from insurance recovery                                          -                  -               11.4
Dividends paid                                                        (39.1)             (38.8)             (38.6)

Free cash flow                                                    $   132.0          $    21.8          $   (53.7)



Management believes that the presentation of free cash flow provides useful
information to investors regarding our financial condition because it is a
measure of cash generated which management evaluates for alternative uses. It is
management's current intention to use excess cash to fund investments in capital
equipment, acquisition opportunities and consistent dividend payments. Free cash
flow is not a U.S. GAAP financial measure and should not be considered in
isolation of, or as a substitute for, cash flows calculated in accordance with
U.S. GAAP.

                                       39
--------------------------------------------------------------------------------
  Table of Contents
Critical Accounting Policies and Estimates

The preparation of the consolidated financial statements in conformity with
generally accepted accounting principles requires management to make estimates
and assumptions that affect the amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the financial statements and
the reported amounts of revenues and expenses during the reporting
period. Actual results could differ from those estimates. On an on-going basis,
we evaluate our estimates, including those related to bad debts, customer
claims, inventories, pensions and other postretirement benefits, intangible
assets, goodwill, leases, environmental liabilities, income taxes, derivative
instruments and hedging activities and contingencies and litigation.

We believe the following are the critical accounting policies and areas affected by significant judgments and estimates impacting the preparation of our consolidated financial statements.

Allowance for Doubtful Accounts



We maintain an allowance for doubtful accounts for estimated losses resulting
from the failure of our customers to make required payments. We perform ongoing
credit evaluations of our customers and monitor their payment patterns. Should
the financial condition of our customers deteriorate, resulting in an impairment
of their ability to make payments, additional allowances may be required.

Inventories



Inventories are valued at the lower of cost or market for those inventories
determined by the LIFO method. We value other inventory at the lower of cost or
net realizable value, determined by the FIFO and average cost methods. As of
June 30, 2021 and 2020, $107.5 million and $136.3 million of inventory,
respectively, was accounted for using a method other than the LIFO method.

Costs include direct materials, direct labor, applicable manufacturing overhead
and other direct costs. Under the LIFO inventory valuation method, changes in
the cost of raw materials and production activities are recognized in cost of
sales in the current period even though these materials and other costs may have
been incurred at significantly different values due to the length of time of our
production cycle. The prices for many of the raw materials we use have been
volatile. Since we value most of our inventory utilizing the LIFO inventory
costing methodology, rapid changes in raw material costs have an impact on our
operating results. In a period of rising prices, cost of sales expense
recognized under LIFO is generally higher than the cash costs incurred to
acquire the inventory sold. Conversely, in a period of declining raw material
prices, cost of sales recognized under LIFO is generally lower than cash costs
incurred to acquire the inventory sold.

Since the LIFO inventory valuation methodology is designed for annual
determination, interim estimates of the annual LIFO valuation are required. We
evaluate the effects of the LIFO inventory valuation method on an interim basis
by estimating the expected annual LIFO cost based on cost changes to date and
recognize effects that are not expected to be replaced by year-end in the
interim period in which the liquidation occurs. These projections of annual LIFO
inventory valuation reserve changes are updated quarterly and are evaluated
based upon material, labor and overhead costs.

Pension and Other Postretirement Benefits



The amount of net pension expense, which is determined annually, or upon
remeasurement, is based upon the value of the assets in the pension trusts at
the beginning of the fiscal year as well as actuarial assumptions, such as the
discount rate and the expected long-term rate of return on plan assets. The
assumed long-term rate of return on pension plan assets is reviewed at each
year-end based on the plan's investment policies, an analysis of the historical
returns of the capital markets and current interest rates. Based on the current
funding level, the allocation policy for pension plan assets is to have
approximately 60 percent in return seeking assets and 40 percent in liability
matching assets. Return seeking assets include domestic and international
equities and diversified loan funds. Liability matching assets include long
duration bond funds. As the funding level of the plan improves in increments of
5 percent, assets will be shifted from return seeking to liability matching in
increments of 4 percent as a de-risking strategy. The plan discount rate is
determined by reference to the Bond:Link interest rate model based upon a
portfolio of highly rated U.S. corporate bonds with individual bonds that are
theoretically purchased to settle the plan's anticipated cash outflows. The
fluctuations in stock and bond markets could cause actual investment results to
be significantly different from those assumed, and therefore, significantly
impact the valuation of the assets in our pension trusts. Changes in actuarial
assumptions could significantly impact the accounting for the pension assets and
liabilities. If the assumed long-term rate of return on plan assets was changed
by 0.25 percent, the net pension expense would change by $2.7 million. If the
discount rate was changed by 0.25 percent, the net pension expense would change
by $0.9 million.
                                       40

--------------------------------------------------------------------------------

Table of Contents

Long-Lived Assets



Long-lived assets are reviewed for impairment and written down to fair value
whenever events or changes in circumstances indicate that the carrying value may
not be recoverable through estimated future undiscounted cash flows. The amount
of the impairment loss is the excess of the carrying amount of the impaired
assets over the fair value of the assets based upon estimated future discounted
cash flows. We evaluate long-lived assets for impairment by individual business
unit. Changes in estimated cash flows could have a significant impact on whether
or not an asset is impaired and the amount of the impairment.

Goodwill

Goodwill is not amortized but instead is tested at least annually for impairment
as of June 30, or more frequently if events or circumstances indicate that the
carrying amount of goodwill may be impaired. Potential impairment is identified
by comparing the fair value of a reporting unit to its carrying value. If the
carrying value of the reporting unit exceeds its fair value, any impairment loss
is measured by the difference between the carrying value of the reporting unit
and its fair value, not to exceed the carrying amount of goodwill. The
discounted cash flow analysis for each reporting unit tested requires
significant estimates and assumptions related to cash flow forecasts, discount
rates, terminal values and income tax rates. The cash flow forecasts include
significant judgments and assumptions related to revenue growth rates, which
include perpetual growth rates, gross margin and weighted average cost of
capital. The cash flow forecasts are developed based on assumptions about each
reporting unit's markets, product offerings, pricing, capital expenditure and
working capital requirements as well as cost performance.

The discount rates used in the discounted cash flow are estimated based on a
market participant's perspective of each reporting unit's weighted average cost
of capital. The terminal value, which represents the value attributed to the
reporting unit beyond the forecast period, is estimated using a perpetuity
growth rate assumption. The income tax rates used in the discounted cash flow
analysis represent estimates of the long-term statutory income tax rates for
each reporting unit based on the jurisdictions in which the reporting units
operate.

In preparing the financial statements for the quarter ended December 31, 2020,
we identified an impairment triggering event related to the Additive reporting
unit within the PEP segment. This reporting unit has experienced slower than
expected growth due to customers shifting their near-term focus away from this
emerging area as a result of the continuing impacts of the COVID-19 pandemic.
During the quarter ended December 31, 2020 we also made strategic decisions to
reduce resources allocated to the Additive reporting unit to concentrate on the
essential manufacturing business. In light of these decisions and current market
conditions, the pace of growth in the future projections for the Additive
reporting unit were lowered. We determined the goodwill associated with this
reporting unit was impaired and recorded an impairment charge of $52.8 million
during the quarter ended December 31, 2020, which represents the entire balance
of goodwill for this reporting unit. No other asset impairment was identified at
the impairment testing date. The carrying value of the Additive reporting unit
was greater than the fair value by approximately 37.7 percent. For purposes of
the discounted cash flow technique for Additive's fair value, we used a weighted
average cost of capital of 15.5 percent and a terminal growth rate assumption of
3.0 percent. If a terminal growth rate of 4.0 percent was used the Additive
reporting unit would have a carrying value in excess of fair value of
approximately 34.2 percent, still resulting in a full impairment.

As of June 30, 2021 we have three reporting units with goodwill recorded.
Goodwill associated with the SAO reporting unit as of June 30, 2021 was $195.5
million and represents approximately 81 percent of total goodwill as of June 30,
2021. The remaining goodwill is associated with the PEP segment, which includes
two reporting units, Dynamet and Latrobe Distribution, with goodwill recorded as
of June 30, 2021 of $31.9 million and $14.0 million, respectively.

Goodwill associated with the SAO reporting unit is tested at the SAO segment
level. The fair value is estimated using a weighting of discounted cash flows
and the use of market multiples valuation techniques. As of June 30, 2021, the
fair value of the SAO reporting unit exceeded the carrying value by
approximately 26.3 percent. The discounted cash flows analysis for the SAO
reporting unit includes assumptions related to our ability to increase volume,
improve mix, expand product offerings and continue to implement opportunities to
reduce costs over the next several years. For purposes of the discounted cash
flow analysis for SAO's fair value, a weighted average cost capital of 9.0
percent and a terminal growth rate assumption of 3.0 percent were used. If the
long-term growth rate for this reporting unit had been hypothetically reduced by
0.5 percent at June 30, 2021, the SAO reporting unit would have a fair value
that exceeded the carrying value by approximately 22.0 percent.

                                       41
--------------------------------------------------------------------------------
  Table of Contents
All other goodwill is associated with the PEP segment, which includes two
reporting units with goodwill recorded. The fair value is estimated using a
weighting of discounted cash flows and the use of market multiples valuation
techniques for the PEP segment reporting units. The fair values of the two
remaining PEP segment reporting units exceeded their carrying values, in each
case, by 45 percent or more.

The estimate of fair value requires significant judgment. We based our fair
value estimates on assumptions that we believe to be reasonable but that are
unpredictable and inherently uncertain, including estimates of future growth
rates and operating margins and assumptions about the overall economic climate
and the competitive environment for our business units. There can be no
assurance that our estimates and assumptions made for purposes of our goodwill
and identifiable intangible asset testing as of the time of testing will prove
to be accurate predictions of the future. If our assumptions regarding business
projections, competitive environments or anticipated growth rates are not
correct, we may be required to record goodwill and/or intangible asset
impairment charges in future periods, whether in connection with our next annual
impairment testing or earlier, if an indicator of an impairment is present
before our next annual evaluation. We continuously monitor for events and
circumstances that could negatively impact the key assumptions in determining
fair value of the reporting units. Given the ongoing uncertainty driven by the
COVID-19 pandemic, we will continue to evaluate the impact on the reporting
units as adverse changes to these assumptions could result in future
impairments.

Leases



Determination of whether a contract is or contains a lease at contract inception
is based on the presence of identified assets and the right to obtain
substantially all of the economic benefit from or to direct the use of such
assets. When it is determined a lease exists, a right-of-use ("ROU") asset and
corresponding lease liability are recorded on the consolidated balance sheets.
ROU assets represent the right to use an underlying asset for the lease term.
Lease liabilities represent the obligation to make lease payments arising from
the lease. ROU assets are recognized at commencement date at the value of the
lease liability and are adjusted for any prepayments, lease incentives received,
and initial direct costs incurred. Lease liabilities are recognized at lease
commencement date based on the present value of remaining lease payments over
the lease term. As the discount rate implicit in the lease is not readily
determinable in most leases, an incremental borrowing rate is used. Lease terms
include options to extend or terminate the lease when it is reasonably certain
that the option will be exercised. Lease contracts with a term of 12 months or
less are not recorded in the consolidated balance sheets. Fixed lease expense is
recognized for operating leases on a straight-line basis over the lease term.
Lease agreements with lease and non-lease components, are accounted for as a
single lease component for all underlying asset classes. Accordingly, all costs
associated with a lease contract are accounted for as lease costs. Some leasing
arrangements require variable payments that are dependent on usage, output, or
may vary for other reasons, such as insurance and tax payments. The variable
lease payments are not presented as part of the ROU asset or lease liability.

Environmental Expenditures



Environmental expenditures that pertain to current operations or to future
revenues are expensed or capitalized consistent with Carpenter's capitalization
policy for property, plant and equipment. Expenditures that result from the
remediation of an existing condition caused by past operations and that do not
contribute to current or future revenues are expensed. Liabilities are
recognized for remedial activities when the remediation is probable and the cost
can be reasonably estimated. Most estimated liabilities are not discounted to
present value due to the uncertainty as to the timing and duration of expected
costs. For one former operating facility site, due to the routine nature of the
expected costs, the liability for future costs is discounted to present value
over 20 years assuming a discount rate of approximately 3 percent as of June 30,
2021 and 2020.

                                       42
--------------------------------------------------------------------------------
  Table of Contents
Income Taxes

Deferred income taxes result from temporary differences in the recognition of
income and expense for financial and income tax reporting purposes, or
differences between the fair value of assets acquired in business combinations
accounted for as purchases for financial reporting purposes and their
corresponding tax bases. Deferred income taxes represent future tax benefits
(assets) or costs (liabilities) to be recognized when those temporary
differences reverse. We evaluate on a quarterly basis whether, based on all
available evidence, we believe that our deferred income tax assets will be
realizable. Valuation allowances are established when it is estimated that it is
more likely than not that the tax benefit of the deferred tax assets will not be
realized. The evaluation includes the consideration of all available evidence,
both positive and negative, regarding historical operating results including
recent years with reported losses, the estimated timing of future reversals of
existing taxable temporary differences, estimated future taxable income
exclusive of reversing temporary differences and carryforwards, and potential
tax planning strategies which may be employed to prevent an operating loss or
tax credit carryforward from expiring unused. Future realization of deferred
income tax assets ultimately depends upon the existence of sufficient taxable
income within the carryback or carryforward period available under tax law.

Management determines whether a tax position should be recognized in the
financial statements by evaluating whether it is more likely than not that the
tax position will be sustained upon examination by the tax authorities based
upon the technical merits of the position. For those tax positions which should
be recognized, the measurement of a tax position is determined as being the
largest amount of benefit that is greater than 50 percent likely of being
realized upon ultimate settlement. Interest and penalties on estimated
liabilities for uncertain tax positions are recorded as components of the
provision for income taxes.

Derivative Financial Instruments



Our current risk management strategies include the use of derivative instruments
to reduce certain risks. The critical strategies include: (1) the use of
commodity forward contracts to fix the price of a portion of anticipated future
purchases of certain raw materials and energy to offset the effects of changes
in the costs of those commodities; and (2) the use of foreign currency forward
contracts to hedge a portion of anticipated future sales denominated in foreign
currencies, principally the Euro and Pound Sterling, in order to offset the
effect of changes in exchange rates. The commodity forwards and foreign currency
forwards have been designated as cash flow hedges and unrealized net gains and
losses are recorded in the accumulated other comprehensive loss component of
stockholders' equity. The unrealized gains or losses are reclassified to the
statement of operations when the hedged transaction affects earnings or if the
anticipated transactions are no longer expected to occur. We may use interest
rate swaps to maintain a certain level of floating rate debt relative to fixed
rate debt. Interest rate swaps have been designated as fair value hedges.
Accordingly, the mark-to-market values of both the interest rate swap and the
underlying debt obligations are recorded as equal and offsetting gains and
losses in the interest expense component of the consolidated statement of
operations. We have also used forward interest rate swaps to manage the risk of
cash flow variability associated with fixed interest debt expected to be issued.
We also use foreign currency forward contracts to protect certain short-term
asset or liability positions denominated in foreign currencies against the
effect of changes in exchange rates. These positions do not qualify for hedge
accounting and accordingly are marked-to-market at each reporting date through
charges to other income and expense.

New Accounting Pronouncements



For information with respect to new accounting pronouncements and the impact of
these pronouncements on our consolidated financial statements, see Note 3 to
Notes to Consolidated Financial Statements included in Item 8. "Financial
Statements and Supplementary Data".

Off Balance Sheet Arrangements

We had no off balance sheet arrangements during the periods presented.


                                       43
--------------------------------------------------------------------------------
  Table of Contents
Contractual Obligations

At June 30, 2021, we had the following contractual obligations and other commercial commitments and contingencies:



                                                                                               Fiscal Year
($ in millions)                                Total              2022             2023            2024            2025            2026            Thereafter
Long-term debt (1)                          $   700.0          $     -      

$ 300.0 $ - $ - $ - $ 400.0 Estimated interest payments (2)

                 184.2             37.6             37.6            24.2            24.2            24.2                 36.4
Operating leases                                 53.2             10.2              8.6             6.4             4.1             3.4                 20.5
Qualified pension plan contributions
(3)                                              24.0                -                -               -             0.7             5.0                 

18.3


Accrued post-retirement benefits (4)            140.0             14.4             14.8            14.6            14.4            14.3                 67.5
Purchase obligations (5)                        250.3            173.4             54.5            21.2             0.8             0.4                    -
Non-qualified pension benefits (6)               32.8              3.5              3.4             3.4             3.4             3.3                 15.8
Total                                       $ 1,384.5          $ 239.1          $ 418.9          $ 69.8          $ 47.6          $ 50.6          $     558.5

(1) Refer to Note 11 of our Notes to Consolidated Financial Statements included in Item 8. "Financial Statements and Supplementary Data".



(2)    Estimated interest payments for long-term debt were calculated based on
the applicable rates and payment dates for long-term debt outstanding as of June
30, 2021. No interest payments are included for any potential borrowings under
our revolving credit facility.

(3) Qualified pension plan contributions represent required minimum contributions for plan years beginning January 1, 2020 and thereafter. The amounts were calculated based on actuarial valuations as prescribed by pension funding regulations in the United States effective June 30, 2021. Estimated fiscal year contributions have been included through fiscal year 2031. The actual required pension contributions in future periods may be different.



(4)    Postretirement benefits for certain plans may be paid from corporate
assets or certain designated plan assets maintained in a Voluntary Employee
Benefit Association ("VEBA") Trust. During fiscal years 2021, 2020 and 2019,
benefit payments were funded using assets in the VEBA Trust. Estimated fiscal
year postretirement benefit payments have been included through fiscal year
2031.

(5)    We have entered into purchase commitments primarily for various key raw
materials at market related prices, all made in the normal course of business.
The commitments include both fixed and variable price provisions. We used
June 30, 2021 raw material prices for commitments with variable pricing.

(6)    Pension benefits for certain non-qualified plans are paid from corporate
assets. There is no guarantee that future payments will be paid from corporate
assets rather than plan assets.

Market Sensitive Instruments and Risk Management

See "Item 7A. Quantitative and Qualitative Disclosures About Market Risk" for discussion of market sensitive instruments and associated market risk for Carpenter.


                                       44
--------------------------------------------------------------------------------

  Table of Contents
Contingencies

Environmental

We are subject to various federal, state, local and international environmental
laws and regulations relating to pollution, protection of public health and the
environment, natural resource damages and occupational safety and health.
Although compliance with these laws and regulations may affect the costs of our
operations, compliance costs to date have not been material. We have
environmental remediation liabilities at some of our owned operating facilities
and have been designated as a potentially responsible party ("PRP") with respect
to certain third party Superfund waste-disposal sites and other third
party-owned sites. Additionally, we have been notified that we may be a PRP with
respect to other Superfund sites as to which no proceedings have been instituted
against us. Neither the exact amount of remediation costs nor the final method
of their allocation among all designated PRPs at these Superfund sites have been
determined. Accordingly, at this time, we cannot reasonably estimate expected
costs for such matters. The liability for future environmental remediation costs
that can be reasonably estimated is evaluated on a quarterly basis. We accrue
amounts for environmental remediation costs that represent our best estimate of
the probable and reasonably estimable future costs related to environmental
remediation. The liabilities recorded for environmental remediation costs at
Superfund sites, other third party-owned sites and Carpenter-owned current or
former operating facilities remaining at June 30, 2021 and 2020 were $16.0
million and $16.0 million, respectively.

Estimates of the amount and timing of future costs of environmental remediation
requirements are inherently imprecise because of the continuing evolution of
environmental laws and regulatory requirements, the availability and application
of technology, the identification of currently unknown remediation sites and the
allocation of costs among the PRPs. Based upon information currently available,
such future costs are not expected to have a material effect on our financial
position, results of operations or cash flows over the long-term. However, such
costs could be material to our financial position, results of operations or cash
flows in a particular future quarter or year.

Other



We are defending various routine claims and legal actions that are incidental to
our business, and that are common to our operations, including those pertaining
to product claims, commercial disputes, patent infringement, employment actions,
employee benefits, compliance with domestic and foreign laws, personal injury
claims and tax issues. Like many other manufacturing companies in recent years
we, from time to time, have been named as a defendant in lawsuits alleging
personal injury as a result of exposure to chemicals and substances in the
workplace. We provide for costs relating to these matters when a loss is
probable and the amount of the loss is reasonably estimable. The effect of the
outcome of these matters on our future results of operations and liquidity
cannot be predicted because any such effect depends on future results of
operations and the amount and timing (both as to recording future charges to
operations and cash expenditures) of the resolution of such matters. While it is
not feasible to determine the outcome of these matters, we believe that the
total liability from these matters will not have a material effect on our
financial position, results of operations or cash flows over the long-term.
However, there can be no assurance that an increase in the scope of pending
matters or that any future lawsuits, claims, proceedings or investigations will
not be material to our financial position, results of operations or cash flows
in a particular future quarter or year.

                                       45
--------------------------------------------------------------------------------
  Table of Contents
Forward-Looking Statements

This Annual Report on Form 10-K contains forward-looking statements within the
meaning of the Private Securities Litigation Act of 1995. These forward-looking
statements are subject to risks and uncertainties that could cause actual
results to differ from those projected, anticipated or implied. The most
significant of these uncertainties are described in this Form 10-K. They include
but are not limited to: (1) the cyclical nature of the specialty materials
business and certain end-use markets, including aerospace, defense, medical,
transportation, energy, industrial and consumer, or other influences on
Carpenter Technology's business such as new competitors, the consolidation of
competitors, customers, and suppliers or the transfer of manufacturing capacity
from the United States to foreign countries; (2) the ability of Carpenter
Technology to achieve cash generation, growth, earnings, profitability,
operating income, cost savings and reductions, qualifications, productivity
improvements or process changes; (3) the ability to recoup increases in the cost
of energy, raw materials, freight or other factors; (4) domestic and foreign
excess manufacturing capacity for certain metals; (5) fluctuations in currency
exchange rates; (6) the effect of government trade actions; (7) the valuation of
the assets and liabilities in Carpenter Technology's pension trusts and the
accounting for pension plans; (8) possible labor disputes or work stoppages; (9)
the potential that our customers may substitute alternate materials or adopt
different manufacturing practices that replace or limit the suitability of our
products; (10) the ability to successfully acquire and integrate acquisitions;
(11) the availability of credit facilities to Carpenter Technology, its
customers or other members of the supply chain; (12) the ability to obtain
energy or raw materials, especially from suppliers located in countries that may
be subject to unstable political or economic conditions; (13) Carpenter
Technology's manufacturing processes are dependent upon highly specialized
equipment located primarily in facilities in Reading and Latrobe, Pennsylvania
and Athens, Alabama for which there may be limited alternatives if there are
significant equipment failures or a catastrophic event; (14) the ability to hire
and retain key personnel, including members of the executive management team,
management, metallurgists and other skilled personnel; (15) fluctuations in oil
and gas prices and production; (16) uncertainty regarding the return to service
of the Boeing 737 MAX aircraft and the related supply chain disruption; (17)
potential impacts of the COVID-19 pandemic on our operations, financial results
and financial position; (18) our efforts and efforts by governmental authorities
to mitigate the COVID-19 pandemic, such as travel bans, shelter in place orders
and business closures, and the related impact on resource allocations and
manufacturing and supply chains; (19) our status as a "critical", "essential" or
"life-sustaining" business in light of COVID-19 business closure laws, orders
and guidance being challenged by a governmental body or other applicable
authority; (20) our ability to execute our business continuity, operational,
budget and fiscal plans in light of the COVID-19 pandemic; and (21) our ability
to successfully carry out restructuring and business exit activities on the
expected terms and timelines. Any of these factors could have an adverse and/or
fluctuating effect on Carpenter Technology's results of operations. The
forward-looking statements in this document are intended to be subject to the
safe harbor protection provided by Section 27A of the Securities Act of 1933, as
amended (the "Securities Act"), and Section 21E of the Securities Exchange Act
of 1934, as amended. Carpenter Technology undertakes no obligation to update or
revise any forward-looking statements.

                                       46

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses